Latest Schedule 13G passive stakes

BlackRock, Inc. has filed an amended Schedule 13G, disclosing beneficial ownership of 8.0% of PRA Group Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 11.9% in EPAM Systems Inc. as of June 30, 2026, primarily through its iShares Core S&P Small-Cap ETF.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 10.4% of MACOM Technology Solutions Holdings Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 14.0% in Warby Parker Inc. Class A Stock as of June 30, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 6.9% in Vital Farms, Inc. as of June 30, 2026, holding 2,964,518 shares.

BlackRock, Inc. has reported a beneficial ownership of 6.7% in Grid Dynamics Holdings, Inc. Class A Stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 13.9% of NETSTREIT Corp.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 11.9% of Liquidia Corp's common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 7.7% in Embecta Corp's common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 7.7% in Embecta Corp's common stock as of June 30, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 11.9% in EPAM Systems Inc. as of June 30, 2026, primarily through its iShares Core S&P Small-Cap ETF.

BlackRock, Inc. has reported beneficial ownership of 5.4% of Forward Air Corp's common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 6.7% in Grid Dynamics Holdings, Inc. Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 7.4% of Insteel Industries Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 11.9% of Liquidia Corp's common stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 10.4% of MACOM Technology Solutions Holdings Inc. common stock as of June 30, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 17.6% in National Health Investors Inc. as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 13.9% of NETSTREIT Corp.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing beneficial ownership of 8.0% of PRA Group Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 10.4% of Pool Corp's common stock as of June 30, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 667,843 shares, representing 1.9% of the outstanding common stock of Resources Connection, Inc., as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G amendment, reporting a 0% beneficial ownership of Sleep Number Corporation's common stock as of June 30, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 6.9% in Vital Farms, Inc. as of June 30, 2026, holding 2,964,518 shares.

BlackRock, Inc. has reported a beneficial ownership of 14.0% in Warby Parker Inc. Class A Stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 11.0% of Autodesk Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 8.2% of Ethan Allen Interiors Inc. common stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 7.5% of Oxford Industries Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 9.5% of VIAVI Solutions Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 10.7% in Concentrix Corp as of June 30, 2026, holding over 6.5 million shares.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 9,356,551 shares, representing 7.2% of the outstanding common stock of Cytek Biosciences, Inc. as of June 30, 2026.